JNBA Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.87K | Hold |
3
| – | – | ﹤0.01% | 723 |
|
|
2026
Q1 | $2.32K | Hold |
3
| – | – | ﹤0.01% | 717 |
|
|
2025
Q4 | $2.32K | Buy |
+3
| New | +$2.04K | ﹤0.01% | 658 |
|
|
2023
Q3 | – | Sell |
-10
| Closed | -$7.19K | – | 760 |
|
|
2023
Q2 | $7.19K | Hold |
10
| – | – | ﹤0.01% | 501 |
|
|
2023
Q1 | $8.22K | Hold |
10
| – | – | ﹤0.01% | 499 |
|
|
2022
Q4 | $7.21K | Sell |
10
-5
| -33% | -$3.69K | ﹤0.01% | 484 |
|
|
2022
Q3 | $10K | Hold |
15
| – | – | ﹤0.01% | 458 |
|
|
2022
Q2 | $9K | Hold |
15
| – | – | ﹤0.01% | 502 |
|
|
2022
Q1 | $10K | Hold |
15
| – | – | ﹤0.01% | 497 |
|
|
2021
Q4 | $9K | Hold |
15
| – | – | ﹤0.01% | 540 |
|
|
2021
Q3 | $9K | Hold |
15
| – | – | ﹤0.01% | 530 |
|
|
2021
Q2 | $8K | Hold |
15
| – | – | ﹤0.01% | 509 |
|
|
2021
Q1 | $7K | Hold |
15
| – | – | ﹤0.01% | 501 |
|
|
2020
Q4 | $7K | Hold |
15
| – | – | ﹤0.01% | 472 |
|
|
2020
Q3 | $8K | Buy |
15
+5
| +50% | +$3.03K | ﹤0.01% | 440 |
|
|
2020
Q2 | $6K | Hold |
10
| – | – | ﹤0.01% | 446 |
|
|
2020
Q1 | $5K | Hold |
10
| – | – | ﹤0.01% | 450 |
|
|
2019
Q4 | $4K | Sell |
10
-16
| -62% | -$5.38K | ﹤0.01% | 513 |
|
|
2019
Q3 | $7K | Buy |
26
+13
| +100% | +$3.85K | ﹤0.01% | 452 |
|
|
2019
Q2 | $4K | Hold |
13
| – | – | ﹤0.01% | 536 |
|
|
2019
Q1 | $5K | Buy |
13
+10
| +333% | +$4.12K | ﹤0.01% | 454 |
|
|
2018
Q4 | $1K | Buy |
+3
| New | +$1.1K | ﹤0.01% | 509 |
|
|
2018
Q3 | – | Sell |
-3
| Closed | -$1K | – | 658 |
|
|
2018
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 518 |
|
|
2018
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 486 |
|
|
2017
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 469 |
|
|
2017
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 463 |
|
|
2017
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 445 |
|
|
2017
Q1 | $1K | Sell |
3
-19
| -86% | -$7.04K | ﹤0.01% | 454 |
|
|
2016
Q4 | $8K | Sell |
22
-55
| -71% | -$20.9K | ﹤0.01% | 381 |
|
|
2016
Q3 | $31K | Buy |
+77
| New | +$30.9K | ﹤0.01% | 671 |
|
|
2014
Q4 | – | Sell |
-5
| Closed | -$2K | – | 583 |
|
|
2014
Q3 | $2K | Buy |
+5
| New | +$1.68K | ﹤0.01% | 532 |
|
Other funds holding REGN
JNBA Financial Advisors's REGN Position: Q2 2026 in Review
JNBA Financial Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 3 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #723.
JNBA Financial Advisors first reported a position in REGN in Q3 2014 and has held it in 31 quarters since. The position peaked at $31K in Q3 2016. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- JNBA Financial Advisors held 3 shares of Regeneron Pharmaceuticals worth $1.87K as of Q2 2026.
- JNBA Financial Advisors left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q2 2026, its #723 holding.
- JNBA Financial Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2014 and has held it in 31 quarters since.
- JNBA Financial Advisors's Regeneron Pharmaceuticals position peaked at $31K in Q3 2016.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.